5 completed, 2 recruiting. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 5, Recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Aalborg University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis Dietary Supplement: Pancreatic enzyme preparation from microbial source that contains amylase (6650 DU), lipase (13000 FIP), and protease (7120 HUT, 15 SAPU, 3000 PC)., Standard of care porcine pancreatic enzyme preparation: amylase (8000 U), lipase (25000 U), and protease (1000 U) - Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency (EPI) | Phase 3 | Recruiting | Asian Institute of Gastroenterology, India | 134 | 2026-10-12 | 2026-10-26 |
| Faecal Microbiota Transplantation for Liver Cirrhosis Faecal microbiota transplantation, Placebo - Liver Cirrhosis | Phase 2 / Phase 3 | Recruiting | University of Aarhus | 220 | 2021-07-01 | 2025-01-24 |
| PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation Apixaban Oral Tablet, Dabigatran, Edoxaban Tablets - Atrial Fibrillation, Intracerebral Hemorrhage | Phase 3 | Completed | Imperial College London | 319 | 2019-06-03 | 2025-01-13 |
| Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. Cinacalcet 30 mg Tablet, Denosumab Inj 60 mg/ml, Placebo tablets - Primary Hyperparathyroidism, Parathyroid Adenoma | Phase 3 | Completed | Peter Vestergaard | 46 | 2017-03-01 | 2021-05-25 |
| A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine D3 Vitamin ®, Placebo - Migraine According to International Headache Society (IHS) Criteria (ICHD-II) | Phase 3 | Completed | Aalborg University | 48 | 2012-09-01 | 2015-12-29 |
| Linking Altered Central Pain Processing and Genetic Polymorphism to Drug Efficacy in Chronic Low Back Pain (Predictio) Oxycodone 15mg, Clobazam, Imipramine - Low Back Pain | Phase 3 | Completed | Insel Gruppe AG, University Hospital Bern | 150 | 2010-07-01 | 2016-04-06 |
| Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities unfractionated heparin, Tinzaparin (Leo) - Deep Venous Thrombosis | Phase 3 | Completed | Aalborg University Hospital | 99 | 1993-10-01 | 2008-03-05 |
Arrhythmias, Cardiac (1) · Ascites (1) · Atrial Fibrillation (1) · Basal Ganglia Hemorrhage (1) · Cerebral Hemorrhage (1) · Exocrine Pancreatic Insufficiency (1) · Gastrointestinal Hemorrhage (1) · Hepatic Encephalopathy (1) · Hepatitis, Alcoholic (1) · Hepatorenal Syndrome (1) · Hyperparathyroidism, Primary (1) · Intracranial Hemorrhages (1) · Liver Cirrhosis (1) · Low Back Pain (1) · Migraine Disorders (1)
Cholecalciferol (1) · Cinacalcet (1) · Clobazam (1) · Dabigatran (1) · Denosumab (1) · Fecal Microbiota Transplantation (1) · Heparin (1) · Imipramine (1) · Lipase (1) · Oxycodone (1) · Peptide Hydrolases (1) · Rivaroxaban (1) · Sodium Chloride (1) · Tablets (1) · Tinzaparin (1)
Denmark (4) · Austria (1) · France (1) · Germany (1) · India (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Andreas Siegenthaler, Dr Med (1) · Benedicte Laursen, MD, DMSc (1) · Julius Simoni Leere, MD (1) · Michele Curatolo, Prof (1) · Parisa Gazerani, Pharm D, PhD (1) · Pascal H Vuilleumier, Dr Med (1) · Peter Vestergaard, DMSc (1) · Roland E Veltkamp, FESO (1) · Rupjyoti Talukdar, MD (1)
PMID 16215338, PMID 16616268, PMID 18654615, PMID 19380256, PMID 26376691, PMID 28850362, PMID 30182753, PMID 32333877, PMID 34022170, PMID 36700520, PMID 39938959, PMID 40023176, PMID 41197104
2016 (1), 2018 (1)